Bismuth tricalium dicitrate, 120 mg 60 pcs

Pharmacotherapeutic group:antiulcer, antiseptic intestinal and astringent.

ATX code: A02BX05

Pharmacological properties

Pharmacodynamics

Gastroprotective and anti-ulcer agent with bactericidal activity against Helicobacter pylori. It also has anti-inflammatory and astringent activity.

In the acidic environment of the stomach, insoluble bismuth oxychloride and citrate are precipitated, chelated compounds with protein substrate are formed in the form of a protective film on the surface of ulcers and erosions. Thus, the drug forms a protective layer, which for a long period of time protects the affected areas of the mucous membrane from the influence of aggressive factors. By increasing the synthesis of prostaglandin E, mucus formation and hydrocarbonate secretion, it stimulates the activity of cytoprotective mechanisms, increases resistance of gastrointestinal mucosa to pepsin, hydrochloric acid, enzymes and salts of bile acids. Leads to the accumulation of epidermal growth factor in the defect area. Reduces the activity of pepsin and pepsinogen.

Pharmacokinetics

It is practically not absorbed from the gastrointestinal tract. It is excreted mainly with the feces. A small amount of bismuth that entered the plasma is excreted by the kidneys.

Indications

Active ingredient

Composition

How to take, the dosage

Interaction

Special Instructions

Impact on ability to drive vehicles and mechanisms

There are no data on the effect of the drug Bismuth tricalium dicitrate on the ability to drive vehicles and mechanisms.

Contraindications

Side effects

Overdose

Pregnancy use

Similarities